Skip to Main Content

Paper Details

Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
Alzheimers Dement
15
2022
Author NameAffiliation
Oscar L LopezUniversity of Pittsburgh School of Medicine
  • 1 - 1

Datasets

Release 1.2